Refined DRGs: Trials in Europe

Jean L. Freeman

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


DRGs have recently been revised to account for severity of illness through a more refined use of additional diagnoses (comorbidities and complications). Under the refined model, patients are differentiated with respect to classes of additional diagnoses that are disease and procedure specific. The Refined DRGs were evaluated with data from selected Barcelona hospitals and the findings compared to those obtained with Norwegian and English hospital discharge information. In terms of predictive performance, the Refined DRGs represent only a very small improvement over the second revision DRGs for the study's sample of European data. This lack of significant improvement is likely attributed to misclassification of the European discharges due to limited reporting of additional diagnoses. It is recommended that European countries use the Refined DRGs as a descriptive framework for reporting utilization statistics In order to encourage more complete reporting of comorbidities and complications.

Original languageEnglish (US)
Pages (from-to)151-164
Number of pages14
JournalHealth policy
Issue number2
StatePublished - Mar 1991
Externally publishedYes


  • Misclassification of discharges
  • Predictive performance of RDRGs
  • RDRGs trials In Europe
  • Refined DRGs

ASJC Scopus subject areas

  • Health Policy


Dive into the research topics of 'Refined DRGs: Trials in Europe'. Together they form a unique fingerprint.

Cite this